These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 15265933)

  • 1. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.
    Bozzacco L; Yu H; Dengjel J; Trumpfheller C; Zebroski HA; Zhang N; Küttner V; Ueberheide BM; Deng H; Chait BT; Steinman RM; Mojsov S; Fenyö D
    PLoS One; 2012; 7(7):e41897. PubMed ID: 22860026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.
    Lazaro E; Kadie C; Stamegna P; Zhang SC; Gourdain P; Lai NY; Zhang M; Martinez SA; Heckerman D; Le Gall S
    J Clin Invest; 2011 Jun; 121(6):2480-92. PubMed ID: 21555856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 variation diminishes CD4 T lymphocyte recognition.
    Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE
    J Exp Med; 1998 Nov; 188(10):1785-93. PubMed ID: 9815256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
    Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
    Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.
    Doody AD; Kovalchin JT; Mihalyo MA; Hagymasi AT; Drake CG; Adler AJ
    J Immunol; 2004 May; 172(10):6087-92. PubMed ID: 15128793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes.
    Tobian AA; Harding CV; Canaday DH
    J Immunol; 2005 May; 174(9):5209-14. PubMed ID: 15843516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.
    Robson NC; McAlpine T; Knights AJ; Schnurr M; Shin A; Chen W; Maraskovsky E; Cebon J
    Blood; 2010 Jul; 116(2):218-25. PubMed ID: 20430956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
    Goulder PJ; Tang Y; Pelton SI; Walker BD
    J Virol; 2000 Jun; 74(11):5291-9. PubMed ID: 10799606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.
    Andrieu M; Desoutter JF; Loing E; Gaston J; Hanau D; Guillet JG; Hosmalin A
    J Virol; 2003 Jan; 77(2):1564-70. PubMed ID: 12502869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining MHC class II T helper epitopes for WT1 tumor antigen.
    Kobayashi H; Nagato T; Aoki N; Sato K; Kimura S; Tateno M; Celis E
    Cancer Immunol Immunother; 2006 Jul; 55(7):850-60. PubMed ID: 16220325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
    Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
    Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
    Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
    J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.
    Steers NJ; Currier JR; Kijak GH; di Targiani RC; Saxena A; Marovich MA; Kim JH; Michael NL; Alving CR; Rao M
    J Virol; 2011 Feb; 85(4):1541-53. PubMed ID: 21106750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.